TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration
Clinical trial NCT05461339 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05461339
- Sponsor
- BioDlink Biopharm Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2024-09-20
- Enrollment
- 488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.